Pharma retail market entry
Expertise, data and delivery combined in a resilient solution.
Learn more →
Healthcare retail entry · tiger.PHARMA
tiger.PHARMA helps grocery and drugstore chains, platforms and other retailers decide which medicines and healthcare categories can fit their German operating model, which partnership structure is viable and what must be proven before a controlled pilot.
Discuss your challenge →
Services for
GDP.secure.QMS.smart — pharma expertise with a clear operational focus.
Expertise, data and delivery combined in a resilient solution.
Learn more →Expertise, data and delivery combined in a resilient solution.
Learn more →Expertise, data and delivery combined in a resilient solution.
Learn more →Expertise, data and delivery combined in a resilient solution.
Learn more →Expertise, data and delivery combined in a resilient solution.
Learn more →Expertise, data and delivery combined in a resilient solution.
Learn more →Expertise, data and delivery combined in a resilient solution.
Learn more →Germany · pharma retail market entry · grocery, drugstore and platforms
tiger.PHARMA helps grocery and drugstore chains, platforms and other retailers decide which medicines and healthcare categories can fit their German operating model, which partnership structure is viable and what must be proven before a controlled pilot.
A German retail opportunity starts with product classification, not a shelf plan. Non-prescription does not automatically mean sale outside pharmacies. We translate the legal status of each product into a go/no-go decision, assortment matrix, partner and supply-chain model, data requirements, operating controls and a measurable pilot. Binding legal questions remain subject to current official sources and appropriately qualified German counsel.
tiger.PHARMA Kompetenz
Sale outside pharmacies is not equated with the entire OTC market. Product status, competence, assortment and store process are assessed separately.
The first deliverable is a decision record for the proposed market, channel and product groups. It separates legal feasibility, customer value, economic viability and operational readiness so an attractive category is not mistaken for a permitted or scalable model.
Medicinal products, medical devices, food supplements, food and cosmetics follow different rules. For medicines, prescription status and pharmacy-only or non-pharmacy status must be assessed separately. The classification is verified for the specific product rather than inferred from a brand, indication or the broad term OTC.
Not every healthcare category requires the retailer to become the direct seller. A decision matrix compares own retail, qualified pharmacy partnership, shop-in-shop, referral and platform structures, including who owns stock, contracts with the customer, provides professional information and manages complaints and returns.
The assortment matrix connects regulatory status with demand, supplier reliability, shelf life, storage, traceability, claims, pricing and omnichannel data. This prevents a commercial range from outrunning the operating controls needed to support it.
A limited pilot tests compliance, customer understanding, availability and operational performance together. Rollout follows only when defined evidence gates are met and deviations have been investigated and corrected.
FAQ
Not automatically. Non-prescription status does not by itself mean that a medicine may be sold outside pharmacies. The exact status and the applicable operating requirements must be verified for each product.
A partnership, referral, shop-in-shop or platform model may be appropriate, but the seller, pharmacy operator, professional responsibility, data, payment, advertising, delivery, complaints and returns must remain clearly allocated.
At minimum: documented classification, approved channel and responsibilities, qualified suppliers, storage and data controls, staff guidance, customer communication, returns and recall procedures, escalation routes and measurable go/adapt/stop criteria.
No. tiger.PHARMA structures the market-entry, operating, supply and evidence work. Binding legal questions are verified against current official sources and, where required, appropriately qualified German legal or regulatory specialists.
Contact
Contact in 10 seconds – clear, direct and in your language.